Alexion loses CEO & CFO as internal investigation continues
December 12, 2016Business Services, Manufacturing and Production, Medical Communications
Alexion Pharmaceuticals has revealed that its CEO David Hallal and CFO Vikas Sinha have resigned effective immediately in connection with …
Scottish Medicines Consortium approves Sanofi’s prostate cancer drug
December 12, 2016Manufacturing and Production, Sales and Marketing Jevtana, Sanofi, prostate cancer
Sanofi’s speciality care global business unit Sanofi Genzyme has announced that the Scottish Medicines Consortium has accepted the company’s Jevtana …
Rare challenges: Meeting patient needs and delivering medical innovation in ultra-rare diseases
December 12, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, ultra rare disease, ultra-rare disease
Dr Emma Harvey, senior medical director at Alexion Pharmaceuticals UK, shares her views on the challenges of working in the …
Personalised leukaemia vaccine shows promise in new trial
December 12, 2016Sales and Marketing leukaemia
A personalised cancer vaccine has proven to have significant efficacy in the treatment of acute myeloid leukaemia (AML), researchers at …
Phase 3 eye drug combo failure for Novartis
December 12, 2016Research and Development, Sales and Marketing Novartis, ophthotech
Novartis’ has failed in its attempt to expand the applications of its anti-VEGF eye treatment Lucentis (ranibizumab) after the drug …
Neurodegenerative market to be worth $45 billion by 2022
December 12, 2016Sales and Marketing Biogen, GBI Research, Novartis, Roche, Sanofi, neurodegenerative
Neurodegenerative disorders including Alzheimer’s, Parkinson’s, Huntington’s, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) form a lucrative worldwide market which …
First generic copy of Roche’s Tamiflu hits US market
December 12, 2016Sales and Marketing Alvogen, Roche, Tamiflu
Drugmaker Alvogen has released the first generic version of Roche’s flu medication Tamiflu (oseltamivir) in the US, where it expects …
AZ and Lilly come together to battle Alzheimer’s
December 9, 2016Research and Development, Sales and Marketing AZ, lilly
Pharma titans Eli Lilly and AstraZeneca have announced they are to join forces to co-develop a potential Alzheimer’s treatment, currently …
Top Ten most popular articles on Pharmafile.com this week
December 9, 2016Medical Communications top ten
Christmas is drawing ever closer, but that doesn’t mean the industry is slowing down. This week, features from the latest …
AZ to terminate 700 US jobs
December 9, 2016Manufacturing and Production, Medical Communications AstraZeneca, job cuts
AstraZeneca has revealed that it plans to cut 700 positions across the US by 10 February 2017, including 120 positions …
Top Pharmaceutical Markets 2016: China
December 9, 2016Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing China, market analysis
Originally featured in Pharmafile Autumn 2016, a report from the United States International Trade Administration sheds light on the Chinese …
Flickering LEDs could light the way for new Alzheimer’s treatment
December 8, 2016Medical Communications, Research and Development Alzheimer's, Cognito therapeutics, mice
Research to find a potential new treatment for Alzheimer’s was hit a blow late last month, as Eli Lilly discontinued …
European thumbs up for Abbvie leukaemia drug
December 8, 2016Medical Communications, Sales and Marketing AbbVie, Venclyxto
Abbvie has confirmed its Venclyxto (venetoclax) has been granted marketing authorisation by the European Commission (EC) as a monotherapy for …
Novartis’ drug doubly effective as chemotherapy for treating lung cancer
December 8, 2016NSCLC, Novartis, chemotherapy
Novartis have released that its drug, Zykadia, in Phase III trials, was twice as effective at slowing progression in advanced …
Teva embroiled in internal bribery investigation
December 8, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, bribery
Israeli pharmaceutical firm Teva has confirmed it is embroiled in an ongoing internal investigation into allegations of bribery, after the …
Mylan to restructure and slash around 10% of workforce
December 8, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, epipen, job losses
Mylan has submitted a regulatory filing to the Securities and Exchange Commission to announce that it would be potentially cutting …
BMS shares promising Opdivo/Yervoy data for advanced bladder cancer
December 8, 2016Research and Development BMS, Yervoy, opdivo
BMS has revealed new efficacy data on the combination of its immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab) for the treatment …
New Alzheimer’s research edges closer to treatment & prevention
December 7, 2016Research and Development Alzheimer's
A new study has shed light on the possible prevention and treatment of Alzheimer’s disease thanks to findings centred on …
AbbVie links up with Johns Hopkins University in cancer research
December 7, 2016Medical Communications
AbbVie has announced that it has agreed a five-year collaboration agreement with Johns Hopkins University. The aim of the collaboration …
AstraZeneca’s Lisa Anson appointed president of ABPI
December 7, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Lisa Anson, current president of AstraZeneca UK & Ireland, has been appointed to the position of president of ABPI. Lisa …
